Kestra Medical Technologies Ltd. (KMTS) Price & Analysis

Compare

15 Followers

KMTS Stock Chart & Stats

$26.85

Market closed

$26.85

Day’s Range― - ―

52-Week Range$13.25 - $30.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)310.69K

Market Cap

$1.38B

Enterprise Value$689.90M

Total Cash (Recent Filing)$201.21M

Total Debt (Recent Filing)$3.10M

Price to Earnings (P/E)―

Beta1.17

Next Earnings

Dec 11, 2025

EPS Estimate

-0.59

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.50

Shares Outstanding57,449,055

10 Day Avg. Volume502,173

30 Day Avg. Volume310,694

Financial Highlights & Ratios

PEG Ratio-0.69

Price to Book (P/B)-5.17

Price to Sales (P/S)38.89

P/FCF Ratio-12.76

Enterprise Value/Market Cap0.50

Enterprise Value/Revenue13.35

Enterprise Value/Gross Profit29.96

Enterprise Value/Ebitda-7.31

Forecast

1Y Price Target

$30.00

Price Target Upside11.73% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)-2.28

Revenue Forecast (FY)$88.10M

Bulls Say, Bears Say

Bulls Say

Earnings GuidanceFY2026 guidance of $85m was set $2m above the Street’s current estimate of $83m.

Gross Margin ExpansionGross margins of 44.3% in the quarter compared to 13.9% in the prior year period, driven by volume leverage and improving revenue conversion.

Revenue Growth4QFY25 revenue of $17.2 million increased 71% YoY and came in +10% ahead of consensus data.

Bears Say

Adjusted EBITDA LossA 4Q adjusted EBITDA loss of $20.3 million was greater than expected, reflecting higher investment into the company’s commercial strategy.

Operating ExpensesOperating expense in FQ4 was slightly higher than expected due to public company costs and investments in the commercial organization following the hiring of the Chief Commercial Officer.

Kestra Medical Technologies Ltd. News

Kestra Medical 6.0M share Secondary priced at $23.00

The deal size was increased to 6.0M shares from 5.5M and priced below last closing price of $23.01....

6d ago

KMTS

Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK

The major averages were broadly lower near noon, starting the month in the red as investors await fresh...

7d ago

Kestra Medical announces underwritten public offering of 5.5M shares

Kestra Medical (KMTS) Technologies announced an underwritten public offering of 5,500,000 common shares. Kestra is offering these shares...

7d ago

KMTS

Kestra Medical sees Q2 revenue $22.2M-$22.6M, consensus $20.73M

“Revenue is expected to grow by over 50% in the second quarter and continues to exceed our FY26...

7d ago

KMTS

Kestra Medical management to meet with Piper Sandler

Meetings to be held in Chicago/Denver/Milwaukee November 19-20 hosted by Piper Sandler. Published first on TheFly – the...

18d ago

KMTS

Kestra Medical initiated with a Buy at BTIG

BTIG initiated coverage of Kestra Medical (KMTS) with a Buy rating and $32 price target The firm says...

20d ago

KMTS

Kestra announces results from ASSURE WCD clinical evaluation post-approval study

Kestra Medical (KMTS) announced primary results from the ASSURE WCD Clinical Evaluation Post-Approval Study, presented as a late-breaking...

28d ago

KMTS

Kestra Medical Raises $148.4 Million in Public Offering

The latest announcement is out from Kestra Medical Technologies Ltd. ( ($KMTS) ). On December 4, 2025, Kestra...

4d ago

KMTS

Kestra Medical Unveils Positive ASSURE Study Results

Kestra Medical Technologies Ltd. ( ($KMTS) ) just unveiled an announcement. On November 10, 2025, Kestra Medical Technologies...

28d ago

KMTS

Kestra’s ASSURE WCD Study: A Game Changer in Cardiac Care?

Kestra Medical Technologies Ltd. (($KMTS)) announced an update on their ongoing clinical study. The ASSURE WCD Clinical Evaluation...

1M ago

KMTS

Kestra Medical appoints Timothy Moran as CBO

Kestra Medical (KMTS) Technologies announced the appointment of Timothy Moran as Chief Business Officer, effective November 3. In...

2M ago

KMTS

Kestra Medical showcases Cardiac Recovery System platform at HFSA 2025

Kestra Medical (KMTS) Technologies announced its debut at the 2025 Heart Failure Society of America Annual Scientific Meeting,...

2M ago

KMTS

Kestra Medical appoints Kwo as independent director

Kestra Medical (KMTS) Technologies announced the appointment of Elizabeth Kwo, M.D. as an independent director to its board...

3M ago

KMTS

Kestra Medical Technologies Reports Strong Growth Amid Challenges

Kestra Medical Technologies Ltd. (($KMTS)) has held its Q1 earnings call. Read on for the main highlights of...

3M ago

KMTS

KMTS FAQ

What was Kestra Medical Technologies Ltd.’s price range in the past 12 months?

Kestra Medical Technologies Ltd. lowest stock price was $13.25 and its highest was $30.00 in the past 12 months.

What is Kestra Medical Technologies Ltd.’s market cap?

Kestra Medical Technologies Ltd.’s market cap is $1.38B.

When is Kestra Medical Technologies Ltd.’s upcoming earnings report date?

Kestra Medical Technologies Ltd.’s upcoming earnings report date is Dec 11, 2025 which is in 3 days.

How were Kestra Medical Technologies Ltd.’s earnings last quarter?

Kestra Medical Technologies Ltd. released its earnings results on Sep 11, 2025. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.61 by $0.11.

Is Kestra Medical Technologies Ltd. overvalued?

According to Wall Street analysts Kestra Medical Technologies Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Kestra Medical Technologies Ltd. pay dividends?

Kestra Medical Technologies Ltd. does not currently pay dividends.

What is Kestra Medical Technologies Ltd.’s EPS estimate?

Kestra Medical Technologies Ltd.’s EPS estimate is -0.59.

How many shares outstanding does Kestra Medical Technologies Ltd. have?

Kestra Medical Technologies Ltd. has 57,449,055 shares outstanding.

What happened to Kestra Medical Technologies Ltd.’s price movement after its last earnings report?

Kestra Medical Technologies Ltd. reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.61. Following the earnings report the stock price went up 18.641%.

Which hedge fund is a major shareholder of Kestra Medical Technologies Ltd.?

Currently, no hedge funds are holding shares in KMTS

Kestra Medical Technologies Ltd. Stock Smart Score

Neutral

Company Description

Kestra Medical Technologies Ltd.

Kestra Medical Technologies Ltd. (KMTS) is a pioneering company in the medical technology sector, specializing in the development and commercialization of innovative healthcare solutions. The company focuses on creating advanced medical devices and diagnostic tools aimed at enhancing patient care and improving clinical outcomes. KMTS's core products include wearable health monitoring devices and telehealth platforms that leverage cutting-edge technology to provide real-time data and analytics for healthcare professionals.

Kestra Medical Technologies Ltd. (KMTS) Earnings & Revenues

Historic Earnings Reports

KMTS Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call highlights significant revenue growth, gross margin expansion, and strategic achievements such as the increased in-network patient percentage and FDA study milestones. However, these positive aspects are tempered by ongoing net losses and increased operating expenses.View all KMTS earnings summaries

KMTS Stock 12 Month Forecast

Average Price Target

$30.00

▲(11.73% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"$14","33":"$33","18.75":"$18.75","23.5":"$23.5","28.25":"$28.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$32.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$28.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,18.75,23.5,28.25,33],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.69,25.252307692307692,25.814615384615387,26.376923076923077,26.939230769230768,27.501538461538463,28.063846153846153,28.626153846153848,29.18846153846154,29.75076923076923,30.313076923076924,30.875384615384615,31.43769230769231,{"y":32,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.69,25.09846153846154,25.506923076923076,25.915384615384617,26.323846153846155,26.732307692307693,27.14076923076923,27.54923076923077,27.95769230769231,28.366153846153846,28.774615384615384,29.183076923076925,29.591538461538462,{"y":30,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.69,24.944615384615386,25.19923076923077,25.453846153846154,25.70846153846154,25.963076923076922,26.21769230769231,26.472307692307695,26.72692307692308,26.981538461538463,27.236153846153847,27.49076923076923,27.745384615384616,{"y":28,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.99,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.58,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.84,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.12,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.15,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.38,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.69,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >